SEC Form 4 · accession 0000899243-18-015835
Cardiff Oncology, Inc. · CRDF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Stanley Tennant
Director
Period of report
Jun 8, 2018
Accepted (ET)
Jun 11, 2018 · 6:03 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001213037
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 8, 2018 | P | 10,000 | $0.80 | A | 236,061 | D |
Table II — derivative securities
No Table II lines on this filing.